{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T17:25:17Z","timestamp":1782321917865,"version":"3.54.5"},"reference-count":104,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014382","name":"Ipsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014382","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physical Medicine and Rehabilitation Clinics of North America"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.pmr.2025.03.004","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T11:34:36Z","timestamp":1745408076000},"page":"447-463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tackling Tone in Tiny Tots"],"prefix":"10.1016","volume":"36","author":[{"given":"Joshua A.","family":"Vova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"DeGraaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pmr.2025.03.004_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2021.804188","article-title":"The contributions of extracellular matrix and sarcomere properties to passive muscle stiffness in cerebral palsy","volume":"12","author":"Konno","year":"2022","journal-title":"Front Physiol"},{"issue":"9","key":"10.1016\/j.pmr.2025.03.004_bib2","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00381-007-0396-4","article-title":"Nonoperative management of spasticity in children","volume":"23","author":"Ronan","year":"2007","journal-title":"Childs Nerv Syst"},{"issue":"2","key":"10.1016\/j.pmr.2025.03.004_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21926\/obm.neurobiol.2202120","article-title":"Cerebral palsy: an overview of etiology, types and comorbidities","volume":"6","author":"Vova","year":"2022","journal-title":"OBM Neurobiol"},{"key":"10.1016\/j.pmr.2025.03.004_bib4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.pediatrneurol.2020.10.014","article-title":"Assessments and interventions for spasticity in infants with or at high risk for cerebral palsy: a systematic review","volume":"118","author":"Ayala","year":"2021","journal-title":"Pediatr Neurol"},{"issue":"Suppl. 1","key":"10.1016\/j.pmr.2025.03.004_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/0883073803018001S0401","article-title":"Pathophysiology of pediatric movement disorders","volume":"18","author":"Sanger","year":"2003","journal-title":"J Child Neurol"},{"issue":"1","key":"10.1016\/j.pmr.2025.03.004_bib6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1542\/peds.111.1.e89","article-title":"Classification and definition of disorders causing hypertonia in childhood","volume":"111","author":"Sanger","year":"2003","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.pmr.2025.03.004_bib7","first-page":"827","article-title":"Spastic hypertonia and movement disorders: pathophysiology, clinical presentation, and quantification","volume":"1","author":"Sheean","year":"2009","journal-title":"Pharm Manag PM R"},{"issue":"1","key":"10.1016\/j.pmr.2025.03.004_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ncl.2014.09.002","article-title":"Diagnosis and treatment of dystonia","volume":"33","author":"Jinnah","year":"2015","journal-title":"Neurol Clin"},{"key":"10.1016\/j.pmr.2025.03.004_bib9","doi-asserted-by":"crossref","first-page":"506","DOI":"10.5334\/tohm.383","article-title":"The anatomical basis for dystonia: the motor network model","volume":"7","author":"Jinnah","year":"2017","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"10.1016\/j.pmr.2025.03.004_bib10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/bs.irn.2023.04.004","article-title":"The functional anatomy of dystonia: recent developments","volume":"169","author":"Corp","year":"2023","journal-title":"Int Rev Neurobiol"},{"issue":"3","key":"10.1016\/j.pmr.2025.03.004_bib11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/dmcn.15730","article-title":"Multiple motor disorders in cerebral palsy","volume":"66","author":"Dar","year":"2023","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"10.1016\/j.pmr.2025.03.004_bib12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/dmcn.15300","article-title":"Dystonia in individuals with spastic cerebral palsy and isolated periventricular leukomalacia","volume":"65","author":"Ueda","year":"2023","journal-title":"Dev Med Child Neurol"},{"issue":"4","key":"10.1016\/j.pmr.2025.03.004_bib13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ejpn.2016.02.003","article-title":"Medication use in childhood dystonia","volume":"20","author":"Lumsden","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"issue":"8","key":"10.1016\/j.pmr.2025.03.004_bib14","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/archdischild-2018-316309","article-title":"Pharmacological management of abnormal tone and movement in cerebral palsy","volume":"104","author":"Lumsden","year":"2019","journal-title":"Arch Dis Child"},{"issue":"Suppl 3","key":"10.1016\/j.pmr.2025.03.004_bib15","first-page":"67","article-title":"Pharmacological and neurosurgical interventions for managing dystonia in cerebral palsy: a systematic review update and meta-analysis using GRADE","volume":"62","author":"Bohn","year":"2020","journal-title":"Dev Med Child Neurol"},{"issue":"4","key":"10.1016\/j.pmr.2025.03.004_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12041564","article-title":"Morphological medial gastrocnemius muscle growth in ambulant children with spastic cerebral palsy: a prospective longitudinal study","volume":"12","author":"De Beukelaer","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.pmr.2025.03.004_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2021.620852","article-title":"Skeletal muscle in cerebral palsy: from belly to myofibril","volume":"12","author":"Howard","year":"2021","journal-title":"Front Neurol"},{"issue":"3","key":"10.1016\/j.pmr.2025.03.004_bib18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/dmcn.12073","article-title":"Impaired muscle growth in spastic cerebral palsy","volume":"55","author":"Barrett","year":"2013","journal-title":"Dev Med Child Neurol"},{"issue":"9","key":"10.1016\/j.pmr.2025.03.004_bib19","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1469-8749.2010.03686.x","article-title":"Gross muscle morphology and structure in spastic cerebral palsy: a systematic review","volume":"52","author":"Barrett","year":"2010","journal-title":"Dev Med Child Neurol"},{"issue":"3","key":"10.1016\/j.pmr.2025.03.004_bib20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/dmcn.15018","article-title":"Understanding skeletal muscle in cerebral palsy: a path to personalized medicine?","volume":"64","author":"Howard","year":"2022","journal-title":"Dev Med Child Neurol"},{"issue":"7","key":"10.1016\/j.pmr.2025.03.004_bib21","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/PHM.0000000000000907","article-title":"Quantifying effect of onabotulinum toxin a on passive muscle stiffness in children with cerebral palsy using ultrasound shear wave elastography","volume":"97","author":"Brandenburg","year":"2018","journal-title":"Am J Phys Med Rehabil"},{"issue":"5","key":"10.1016\/j.pmr.2025.03.004_bib22","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1152\/japplphysiol.00278.2018","article-title":"Muscle contracture and passive mechanics in cerebral palsy","volume":"126","author":"Lieber","year":"2019","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.pmr.2025.03.004_bib23","series-title":"StatPearls [Internet]","article-title":"Benzodiazepines. 2024","author":"Bounds","year":"2025"},{"issue":"1","key":"10.1016\/j.pmr.2025.03.004_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.2023-065512","article-title":"Physician approaches to the pharmacologic treatment of dystonia in cerebral palsy","volume":"154","author":"Lott","year":"2024","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.pmr.2025.03.004_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21093184","article-title":"Neonatal clonazepam administration induced long-lasting changes in GABAa and GABAb receptors","volume":"21","author":"Kubov\u00e1","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pmr.2025.03.004_bib26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pediatrneurol.2024.06.004","article-title":"Efficacy of oral trihexyphenidyl plus clonazepam versus trihexyphenidyl for the treatment of dystonia in children with dystonic cerebral palsy: an open-label randomized controlled trial","volume":"158","author":"Kumar Panda","year":"2024","journal-title":"Pediatr Neurol"},{"issue":"3","key":"10.1016\/j.pmr.2025.03.004_bib27","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/pr.2015.237","article-title":"Ontogeny of plasma proteins, albumin and binding of diazepam, cyclosporine, and deltamethrin","volume":"79","author":"Sethi","year":"2016","journal-title":"Pediatr Res"},{"issue":"5","key":"10.1016\/j.pmr.2025.03.004_bib28","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jpeds.2014.01.029","article-title":"Population pharmacokinetics of oral baclofen in pediatric patients with cerebral palsy","volume":"164","author":"He","year":"2014","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.pmr.2025.03.004_bib29","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s40272-017-0243-3","article-title":"Clinical management of dystonia in childhood","volume":"19","author":"Luc","year":"2017","journal-title":"Pediatr Drugs"},{"issue":"7","key":"10.1016\/j.pmr.2025.03.004_bib30","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3109\/09638288.2016.1153162","article-title":"What is the evidence for managing tone in young children with, or at risk of developing, cerebral palsy: a systematic review","volume":"39","author":"Ward","year":"2017","journal-title":"Disabil Rehabil"},{"issue":"2","key":"10.1016\/j.pmr.2025.03.004_bib31","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/0883073811416238","article-title":"Is oral baclofen effective in neonatal hypertonia?","volume":"27","author":"Schulz","year":"2012","journal-title":"J Child Neurol"},{"issue":"1","key":"10.1016\/j.pmr.2025.03.004_bib32","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/sj.jp.7211194","article-title":"The use of baclofen in full-term neonates with hypertonia","volume":"25","author":"Moran","year":"2005","journal-title":"J Perinatol"},{"issue":"Suppl. 3","key":"10.1016\/j.pmr.2025.03.004_bib33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1528-1157.2001.042suppl.3008.x","article-title":"GABAergic mechanisms in epilepsy","volume":"42","author":"Treiman","year":"2001","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.pmr.2025.03.004_bib34","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1528-1157.1995.tb01039.x","article-title":"Age-dependent effects of \u03b3-aminobutyric acid agents on flurothyl seizures","volume":"36","author":"Vel\u00ed\u0161ek","year":"1995","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.pmr.2025.03.004_bib35","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1159\/000244338","article-title":"Moderate anticonvulsant action of baclofendoes not change during development","volume":"69","author":"Kubov\u00e1","year":"1996","journal-title":"Neonatology"},{"issue":"3","key":"10.1016\/j.pmr.2025.03.004_bib36","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0887-8994(03)00208-X","article-title":"Oral baclofen in cerebral palsy: possible seizure potentiation?","volume":"29","author":"Hansel","year":"2003","journal-title":"Pediatr Neurol"},{"issue":"2","key":"10.1016\/j.pmr.2025.03.004_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11910-020-1022-z","article-title":"State of the evidence traffic lights 2019: systematic review of interventions for preventing and treating children with cerebral palsy","volume":"20","author":"Novak","year":"2020","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"6","key":"10.1016\/j.pmr.2025.03.004_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3171\/2024.3.FOCUS2467","article-title":"Spinal catheter revision in pediatric intrathecal baclofen pumps: risk factors and postoperative outcomes","volume":"56","author":"Mosher","year":"2024","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.pmr.2025.03.004_bib39","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3171\/2015.11.PEDS15421","article-title":"Risk factors for baclofen pump infection in children: a multivariate analysis","volume":"17","author":"Spader","year":"2016","journal-title":"J Neurosurg Pediatr"},{"issue":"4","key":"10.1016\/j.pmr.2025.03.004_bib40","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00381-019-04341-7","article-title":"Intrathecal baclofen therapy for treatment of spasticity in infants and small children under 6 years of age","volume":"36","author":"Hagemann","year":"2020","journal-title":"Childs Nerv Syst"},{"issue":"6","key":"10.1016\/j.pmr.2025.03.004_bib41","first-page":"RC01","article-title":"Prospective randomized study of oral Diazepam and Baclofen on spasticity in cerebral palsy","volume":"10","author":"Goyal","year":"2016","journal-title":"J Clin Diagnostic Res"},{"key":"10.1016\/j.pmr.2025.03.004_bib42","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.brainres.2016.01.021","article-title":"Pharmacotherapy in rehabilitation of post-acute traumatic brain injury","volume":"1640","author":"Bhatnagar","year":"2016","journal-title":"Brain Res"},{"issue":"4","key":"10.1016\/j.pmr.2025.03.004_bib43","article-title":"Clonidine for pain in non-ventilated infants","volume":"2020","author":"Romantsik","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.pmr.2025.03.004_bib44","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ejpn.2017.03.001","article-title":"Clonidine use in the outpatient management of severe secondary dystonia","volume":"21","author":"Sayer","year":"2017","journal-title":"Eur J Paediatr Neurol"},{"issue":"12","key":"10.1016\/j.pmr.2025.03.004_bib45","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1177\/7010.2006.00134","article-title":"Oral baclofen and clonidine for treatment of spacticity in children","volume":"21","author":"Lubsch","year":"2006","journal-title":"J Child Neurol"},{"issue":"Suppl. 1","key":"10.1016\/j.pmr.2025.03.004_bib46","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/0883073803018001S0601","article-title":"Oral pharmacotherapy of childhood movement disorders","volume":"18","author":"Edgar","year":"2003","journal-title":"J Child Neurol"},{"issue":"4","key":"10.1016\/j.pmr.2025.03.004_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/dmcn.13652","article-title":"Pharmacological and neurosurgical interventions for managing dystonia in cerebral palsy: a systematic review","volume":"60","author":"Fehlings","year":"2018","journal-title":"Dev Med Child Neurol"},{"issue":"3","key":"10.1016\/j.pmr.2025.03.004_bib48","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2165\/00003495-199753030-00007","article-title":"Tizanidine. A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders","volume":"53","author":"Wagstaff","year":"1997","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.pmr.2025.03.004_bib49","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/0883073815587030","article-title":"Comparison of efficacy and side effects of oral baclofen versus tizanidine therapy with adjuvant botulinum toxin type A in children with cerebral palsy and spastic equinus foot deformity","volume":"31","author":"Dai","year":"2016","journal-title":"J Child Neurol"},{"issue":"4","key":"10.1016\/j.pmr.2025.03.004_bib50","doi-asserted-by":"crossref","first-page":"240","DOI":"10.26815\/acn.2023.00101","article-title":"Effect of tizanidine on spasticity in pediatric patients with cerebral palsy: a systematic review","volume":"31","author":"Castro","year":"2023","journal-title":"Ann Child Neurol"},{"issue":"04","key":"10.1016\/j.pmr.2025.03.004_bib51","doi-asserted-by":"crossref","first-page":"617","DOI":"10.4236\/ojped.2020.104063","article-title":"Comparison of baclofen and tizanidine in reducing spasticity in cerebral palsy: a randomized control trial","volume":"10","author":"Haque","year":"2020","journal-title":"Open J Pediatr"},{"issue":"6","key":"10.1016\/j.pmr.2025.03.004_bib52","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2165\/11316090-000000000-00000","article-title":"Pediatric safety of tizanidine: clinical adverse event database and retrospective chart assessment","volume":"11","author":"Henney","year":"2009","journal-title":"Pediatr Drugs"},{"issue":"10","key":"10.1016\/j.pmr.2025.03.004_bib53","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/BF02731118","article-title":"Pharmacologic interventions for reducing spasticity in cerebral palsy","volume":"72","author":"Patel","year":"2005","journal-title":"Indian J Pediatr"},{"issue":"9","key":"10.1016\/j.pmr.2025.03.004_bib54","first-page":"839","article-title":"Role of oral medications in spasticity management","volume":"1","author":"Watanabe","year":"2009","journal-title":"Pharm Manag PM R"},{"issue":"3","key":"10.1016\/j.pmr.2025.03.004_bib55","first-page":"207","article-title":"The use of gabapentin for pain and agitation in neonates and infants in a neonatal ICU","volume":"22","author":"Sacha","year":"2017","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.pmr.2025.03.004_bib56","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0920-1211(01)00311-4","article-title":"Population pharmacokinetics of gabapentin in infants and children","volume":"47","author":"Ouellet","year":"2001","journal-title":"Epilepsy Res"},{"issue":"1","key":"10.1016\/j.pmr.2025.03.004_bib57","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejpn.2015.09.007","article-title":"Gabapentin can significantly improve dystonia severity and quality of life in children","volume":"20","author":"Liow","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"issue":"2","key":"10.1016\/j.pmr.2025.03.004_bib58","first-page":"159","article-title":"Evaluating gabapentin dosing, efficacy and safety in infants","volume":"29","author":"Fleser","year":"2024","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.pmr.2025.03.004_bib59","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/dmcn.14324","article-title":"Gabapentin for pain, movement disorders, and irritability in neonates and infants","volume":"62","author":"Burnsed","year":"2020","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.pmr.2025.03.004_bib60","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pediatrneurol.2019.02.012","article-title":"Gabapentin use for hospitalized neonates","volume":"97","author":"Abdi","year":"2019","journal-title":"Pediatr Neurol"},{"issue":"8","key":"10.1016\/j.pmr.2025.03.004_bib61","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1592\/phco.29.8.997","article-title":"Gabapentin therapy for pain and irritability in a neurologically impaired infant","volume":"29","author":"Haney","year":"2009","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.pmr.2025.03.004_bib62","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.cell.2009.09.025","article-title":"Gabapentin receptor \u03b12\u03b4-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis","volume":"139","author":"Eroglu","year":"2009","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.pmr.2025.03.004_bib63","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1152\/jn.00186.2018","article-title":"Differences in lumbar motor neuron pruning in an animal model of early onset spasticity","volume":"120","author":"Brandenburg","year":"2018","journal-title":"J Neurophysiol"},{"issue":"4","key":"10.1016\/j.pmr.2025.03.004_bib64","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/jpc.13754","article-title":"Oral medication prescription practices of tertiary-based specialists for dystonia in children with cerebral palsy","volume":"54","author":"Harvey","year":"2018","journal-title":"J Paediatr Child Health"},{"issue":"1","key":"10.1016\/j.pmr.2025.03.004_bib65","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0887-8994(01)00287-9","article-title":"Age-dependent effects of trihexyphenidyl in extrapyramidal cerebral palsy","volume":"25","author":"Hoon","year":"2001","journal-title":"Pediatr Neurol"},{"issue":"1","key":"10.1016\/j.pmr.2025.03.004_bib66","first-page":"115","article-title":"Trihexyphenidyl in young children with dystonic cerebral palsy: a single arm study","volume":"16","author":"Rajkumar","year":"2023","journal-title":"J Pediatr Rehabil Med"},{"issue":"3","key":"10.1016\/j.pmr.2025.03.004_bib67","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s11940-011-0122-0","article-title":"Treatment of generalized dystonia","volume":"13","author":"Lubarr","year":"2011","journal-title":"Curr Treat Options Neurol"},{"issue":"9","key":"10.1016\/j.pmr.2025.03.004_bib68","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/dmcn.14874","article-title":"Pharmacological and neurosurgical interventions for individuals with cerebral palsy and dystonia: a systematic review update and meta-analysis","volume":"63","author":"Bohn","year":"2021","journal-title":"Dev Med Child Neurol"},{"issue":"9","key":"10.1016\/j.pmr.2025.03.004_bib69","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/dmcn.15921","article-title":"Pharmacological and neurosurgical management of cerebral palsy and dystonia: clinical practice guideline update","volume":"66","author":"Fehlings","year":"2024","journal-title":"Dev Med Child Neurol"},{"issue":"7","key":"10.1016\/j.pmr.2025.03.004_bib70","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1474-4422(16)00132-0","article-title":"Advances in management of movement disorders in children","volume":"15","author":"Koy","year":"2016","journal-title":"Lancet Neurol"},{"issue":"10","key":"10.1016\/j.pmr.2025.03.004_bib71","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1468-1331.2011.03649.x","article-title":"Treatment for dystonia in childhood","volume":"19","author":"Roubertie","year":"2012","journal-title":"Eur J Neurol"},{"issue":"5","key":"10.1016\/j.pmr.2025.03.004_bib72","doi-asserted-by":"crossref","first-page":"E645","DOI":"10.1212\/CPJ.0000000000000989","article-title":"Pediatric dystonic storm","volume":"11","author":"Goswami","year":"2021","journal-title":"Neurol Clin Pract"},{"issue":"11","key":"10.1016\/j.pmr.2025.03.004_bib73","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/mds.21063","article-title":"Tetrabenazine therapy of pediatric hyperkinetic movement disorders","volume":"21","author":"Jain","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.pmr.2025.03.004_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2021.612429","article-title":"A retrospective longitudinal study in a cohort of children with dyskinetic cerebral palsy treated with tetrabenazine","volume":"12","author":"Scalise","year":"2021","journal-title":"Front Neurol"},{"issue":"6","key":"10.1016\/j.pmr.2025.03.004_bib75","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.apmr.2017.11.013","article-title":"Early botulinum toxin injections in infants with musculoskeletal disorders: a systematic review of safety and effectiveness","volume":"99","author":"Bourseul","year":"2018","journal-title":"Arch Phys Med Rehabil"},{"issue":"2","key":"10.1016\/j.pmr.2025.03.004_bib76","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/dmcn.14298","article-title":"Long-term effects of repeated botulinum neurotoxin A, bimanual training, and splinting in young children with cerebral palsy","volume":"62","author":"Lidman","year":"2020","journal-title":"Dev Med Child Neurol"},{"issue":"12\u201314","key":"10.1016\/j.pmr.2025.03.004_bib77","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1177\/08830738221124365","article-title":"Upper limb onabotulinumtoxin A injections in children under 2 Years with cerebral palsy: a retrospective chart review","volume":"37","author":"Centorame","year":"2022","journal-title":"J Child Neurol"},{"issue":"1","key":"10.1016\/j.pmr.2025.03.004_bib78","first-page":"67","article-title":"Safety of botulinum toxin injections in children less than one year old: a retrospective chart review","volume":"17","author":"Deshpande","year":"2024","journal-title":"J Pediatr Rehabil Med"},{"issue":"6\u20137","key":"10.1016\/j.pmr.2025.03.004_bib79","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1177\/08830738231183484","article-title":"Safety and efficacy of botulinum toxin type A in children with spastic cerebral palsy aged <2 Years: a systematic review","volume":"38","author":"Yang","year":"2023","journal-title":"J Child Neurol"},{"issue":"11","key":"10.1016\/j.pmr.2025.03.004_bib80","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3390\/toxins14110772","article-title":"Botulinum toxin intervention in cerebral palsy-induced spasticity management: projected and contradictory effects on skeletal muscles","volume":"14","author":"Kaya Keles","year":"2022","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.pmr.2025.03.004_bib81","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.toxicon.2017.10.027","article-title":"Direct central nervous system effects of botulinum neurotoxin","volume":"147","author":"Caleo","year":"2018","journal-title":"Toxicon"},{"issue":"21","key":"10.1016\/j.pmr.2025.03.004_bib82","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.3346\/jkms.2023.38.e187","article-title":"Decrease of muscle mass in young patients with neuromuscular disease: assessment of sarcopenia","volume":"38","author":"Kim","year":"2023","journal-title":"J Korean Med Sci"},{"issue":"8","key":"10.1016\/j.pmr.2025.03.004_bib83","article-title":"Botulinum toxin in the management of children with cerebral palsy","volume":"139","author":"Multani","year":"2019","journal-title":"Pediatr Drugs"},{"issue":"7","key":"10.1016\/j.pmr.2025.03.004_bib84","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/dmcn.14056","article-title":"Medial gastrocnemius volume and echo-intensity after botulinum neurotoxin A interventions in children with spastic cerebral palsy","volume":"61","author":"Schless","year":"2018","journal-title":"Dev Med Child Neurol"},{"issue":"6","key":"10.1016\/j.pmr.2025.03.004_bib85","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.rehab.2015.06.002","article-title":"Muscle structure and stiffness assessment after botulinum toxin type A injection. A systematic review","volume":"58","author":"Mathevon","year":"2015","journal-title":"Ann Phys Rehabil Med"},{"issue":"4","key":"10.1016\/j.pmr.2025.03.004_bib86","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/mus.24576","article-title":"Dramatic changes in muscle contractile and structrial properties after two botulinum toxin injections","volume":"52","author":"Minamoto","year":"2015","journal-title":"Muscle Nerve"},{"issue":"16","key":"10.1016\/j.pmr.2025.03.004_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells12162072","article-title":"Botulinum toxin treatment of adult muscle stem cells from children with cerebral palsy and hiPSC-derived neuromuscular junctions","volume":"12","author":"Costamagna","year":"2023","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.pmr.2025.03.004_bib88","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.pmr.2023.06.009","article-title":"Spasticity treatment beyond botulinum toxins","volume":"35","author":"Li","year":"2024","journal-title":"Phys Med Rehabil Clin N Am"},{"issue":"20","key":"10.1016\/j.pmr.2025.03.004_bib89","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.3390\/jcm10204723","article-title":"Recent advances in the treatment of spasticity: extracorporeal shock wave therapy","volume":"10","author":"Yang","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.pmr.2025.03.004_bib90","first-page":"1442","article-title":"Clinical diagnosis and treatment of pediatric anti-N-methyl-D-aspartate receptor encephalitis : a single center retrospective study","volume":"16","author":"Sai","year":"2018","journal-title":"Exp Ther Med"},{"issue":"6","key":"10.1016\/j.pmr.2025.03.004_bib91","first-page":"761","article-title":"Effect of extracorporeal shockwave therapy on muscle spasticity in patients with cerebral palsy: systematic review and meta-analysis","volume":"55","author":"Kim","year":"2019","journal-title":"Eur J Phys Rehabil Med"},{"issue":"19","key":"10.1016\/j.pmr.2025.03.004_bib92","first-page":"1","article-title":"A prospective case-control study of radial extracorporeal shock wave therapy for spastic plantar flexor muscles in very young children with cerebral palsy","volume":"95","author":"Wang","year":"2016","journal-title":"Med (United States)"},{"issue":"2","key":"10.1016\/j.pmr.2025.03.004_bib93","doi-asserted-by":"crossref","DOI":"10.3390\/children10020332","article-title":"Effectiveness of extracorporeal shockwave therapy on controlling spasticity in cerebral palsy patients: a meta-analysis of timing of outcome measurement","volume":"10","author":"Chang","year":"2023","journal-title":"Children"},{"issue":"4","key":"10.1016\/j.pmr.2025.03.004_bib94","doi-asserted-by":"crossref","first-page":"565","DOI":"10.23736\/S1973-9087.22.07136-2","article-title":"A systematic review on extracorporeal shock wave therapy and botulinum toxin for spasticity treatment: a comparison on efficacy","volume":"58","author":"Mihai","year":"2022","journal-title":"Eur J Phys Rehabil Med"},{"issue":"4","key":"10.1016\/j.pmr.2025.03.004_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/toxins16040197","article-title":"Effectiveness of extracorporeal shock wave therapy after botulinum toxin injection for post-stroke upper extremity spasticity: a randomized controlled study","volume":"16","author":"Lee","year":"2024","journal-title":"Toxins (Basel)"},{"issue":"12","key":"10.1016\/j.pmr.2025.03.004_bib96","first-page":"1490","article-title":"Hyaluronan homeostasis and its role in pain and muscle stiffness","volume":"14","author":"Amir","year":"2022","journal-title":"Pharm Manag PM R"},{"key":"10.1016\/j.pmr.2025.03.004_bib97","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.pmr.2018.04.004","article-title":"Emerging therapies for spastic movement disorders","volume":"29","author":"Raghavan","year":"2018","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"10.1016\/j.pmr.2025.03.004_bib98","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ebiom.2016.05.014","article-title":"Human recombinant hyaluronidase injections for upper limb muscle stiffness in individuals with cerebral injury: a case series","volume":"9","author":"Raghavan","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.pmr.2025.03.004_bib99","article-title":"Cryoneurotomy to reduce spasticity and improve range of motion in spastic flexed elbow. A visual vignette","volume":"5","author":"Rubenstein","year":"2020","journal-title":"Am J Phys Med Rehabil"},{"issue":"3\u20134","key":"10.1016\/j.pmr.2025.03.004_bib100","article-title":"Cryoneurotomy as a percutaneous mini-invasive therapy for the treatment of the spastic limb: case presentation, review of the literature, and proposed approach for use","volume":"1","author":"Winston","year":"2019","journal-title":"Arch Rehabil Res Clin Transl"},{"key":"10.1016\/j.pmr.2025.03.004_bib101","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1097\/PHM.0000000000002267","article-title":"Analysis of side effects of cryoneurolysis for the treatment of spasticity","volume":"11","author":"Winston","year":"2023","journal-title":"Am J Phys Med Rehabil"},{"issue":"5","key":"10.1016\/j.pmr.2025.03.004_bib102","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/ALN.0000000000003532","article-title":"Cryoneurolysis and percutaneous peripheral nerve stimulation to treat acute pain: a narrative review","volume":"133","author":"Ilfeld","year":"2020","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/j.pmr.2025.03.004_bib103","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1474-4422(23)00004-2","article-title":"Towards functional improvement of motor disorders associated with cerebral palsy","volume":"22","author":"Bekteshi","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.pmr.2025.03.004_bib104","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/dmcn.12531","article-title":"Early identification and intervention in cerebral palsy","volume":"57","author":"Herskind","year":"2015","journal-title":"Dev Med Child Neurol"}],"container-title":["Physical Medicine and Rehabilitation Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047965125000257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047965125000257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T18:35:20Z","timestamp":1751394920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047965125000257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":104,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1047965125000257"],"URL":"https:\/\/doi.org\/10.1016\/j.pmr.2025.03.004","relation":{},"ISSN":["1047-9651"],"issn-type":[{"value":"1047-9651","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tackling Tone in Tiny Tots","name":"articletitle","label":"Article Title"},{"value":"Physical Medicine and Rehabilitation Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pmr.2025.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}